CD274 and cancer: Mechanistically, this study demonstrated that resveratrol targeted the immune evasion of cancer cells by directly disrupting N-glycan branching, leading to the dimerization of PD-L1, thus promoting the de-localization of PD-L1 to the plasma membrane.